Jefferies Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-37,621
| Closed | -$3.08M | – | 1214 |
|
|
2021
Q2 | $3.08M | Buy |
+37,621
| New | +$3.08M | 0.02% | 356 |
|
|
2020
Q4 | – | Sell |
-4,565
| Closed | -$271K | – | 1089 |
|
|
2020
Q3 | $271K | Buy |
+4,565
| New | +$271K | ﹤0.01% | 686 |
|
|
2019
Q2 | – | Sell |
-8,183
| Closed | -$642K | – | 1702 |
|
|
2019
Q1 | $642K | Buy |
8,183
+3,497
| +75% | +$274K | 0.01% | 870 |
|
|
2018
Q4 | $397K | Sell |
4,686
-24,659
| -84% | -$2.09M | ﹤0.01% | 922 |
|
|
2018
Q3 | $5.03M | Sell |
29,345
-43,178
| -60% | -$7.39M | 0.03% | 215 |
|
|
2018
Q2 | $9.37M | Buy |
+72,523
| New | +$9.37M | 0.05% | 104 |
|
|
2017
Q3 | – | Sell |
-2,725
| Closed | -$206K | – | 1664 |
|
|
2017
Q2 | $206K | Buy |
+2,725
| New | +$206K | ﹤0.01% | 1328 |
|
|
2016
Q2 | – | Sell |
-3,527
| Closed | -$236K | – | 1361 |
|
|
2016
Q1 | $236K | Buy |
+3,527
| New | +$236K | ﹤0.01% | 949 |
|
|
2015
Q4 | – | Sell |
-42,574
| Closed | -$2.28M | – | 1411 |
|
|
2015
Q3 | $2.28M | Buy |
42,574
+31,584
| +287% | +$1.69M | 0.01% | 327 |
|
|
2015
Q2 | $692K | Buy |
+10,990
| New | +$692K | ﹤0.01% | 703 |
|
|
2014
Q2 | – | Sell |
-37,396
| Closed | -$1.57M | – | 1508 |
|
|
2014
Q1 | $1.57M | Buy |
+37,396
| New | +$1.57M | 0.02% | 309 |
|